Antinuclear antibody targets in autoimmune hepatitis and drug-induced liver injury: Diagnostic relevance of nucleosome antibodies

Key Points

• Nucleosome antibodies show significant diagnostic potential for identifying autoimmune hepatitis and drug-induced liver injury.
• The study reports a 65% sensitivity and 80% specificity for nucleosome antibodies in diagnosing these conditions.
• Observational analysis across various clinical settings highlights the importance of antinuclear antibody profiling.
• Findings suggest nucleosome antibodies could serve as valuable diagnostic biomarkers for liver-related autoimmune conditions.